mounjaro tirzepatide side effects Effects: A Week-by-Week Guide Mounjaro (Tirzepatide): The Truth Behind

Dyspepsia: 11% of patients in the Wegovy group compared to 3% in the placebo group

It is not recommended for those with certain conditions, such as a history of thyroid cancer or pancreatitis

Summary: Retatrutide is a synthetic peptide medicine engineered to simultaneously activate GLP-1, GIP, and glucagon receptors, making it a triple receptor agonist under clinical investigation for obesity treatment

Patients should work closely with their healthcare team to ensure that their treatment plan addresses both conditions safely and effectively

Y.) 8 , e12268 (2022)

Nausea, vomiting, and diarrhea are common during the first weeks of treatment and usually fade as the body adapts